abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 30th, there was short interest totaling 41,483 shares, a decline of 20.4% from the January 15th total of 52,128 shares. Based on an average trading volume of 207,363 shares, the short-interest ratio is currently 0.2 days. Currently, 0.1% of the company’s shares are sold short. Currently, 0.1% of the company’s shares are sold short. Based on an average trading volume of 207,363 shares, the short-interest ratio is currently 0.2 days.
abrdn Healthcare Investors Stock Performance
Shares of abrdn Healthcare Investors stock traded up $0.27 during midday trading on Friday, hitting $19.86. The company had a trading volume of 230,240 shares, compared to its average volume of 179,093. abrdn Healthcare Investors has a 12-month low of $13.77 and a 12-month high of $19.89. The company has a fifty day simple moving average of $19.14 and a 200 day simple moving average of $18.23.
abrdn Healthcare Investors Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, February 20th will be paid a dividend of $0.63 per share. This is a boost from abrdn Healthcare Investors’s previous quarterly dividend of $0.57. The ex-dividend date of this dividend is Friday, February 20th. This represents a $2.52 annualized dividend and a yield of 12.7%.
Institutional Inflows and Outflows
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Featured Stories
- Five stocks we like better than abrdn Healthcare Investors
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
